GLAXOSMITHKLINE EXERCISES OPTION TO LYMPHOSTAT-B - HGS
Human Genome Sciences is an emerging pharmaceutical company with the mission to predict, prevent, detect, treat and cure disease.HUMAN GENOME SCIENCES AND GLAXOSMITHKLINE INITIATE SECOND PHASE 3 ...
Human Genome Sciences is an emerging pharmaceutical company with the mission to ... LymphoStat-B is being developed by HGS and GlaxoSmithKline (GSK) under a ...Human Genome Sciences announces positive phase 2 LymphoStat-B results
Human Genome Sciences, Inc. has announced the presentation of Phase 2 clinical results demonstrating that LymphoStat-B (belimumab) achieved a sustained improvement ...Research - Lupus Foundation of America, Inc.
Positive Results of Phase I Study Put LymphoStat-B on Fast Track for Drug Development ... There is no cure for lupus, and lupus can be fatal in some cases. ...Human Genome Sciences, Inc.'s Lupus Drug Shows Positive Mid-Stage Trial ...
This provides us with a substantial body of data on the long-term effects of LymphoStat-B. ... LymphoStat-B was generated by HGS through a collaboration with ...Positive Long-Term Data For BENLYSTA (formerly LYMPHOSTAT-B(R)) In ...
Human Genome Sciences (HGS) has reported continuation data from a Phase II study of BENLYSTA™ (belimumab, formerly LymphoStat-B®) showing sustained improvement in ...